Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IONS
IONS logo

IONS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IONS News

FDA Approves High Dose SPINRAZA for SMA Treatment

1d agoNewsfilter

GSK Seeks EMA Approval for Bepirovirsen in Chronic Hepatitis B Treatment

4d agoNASDAQ.COM

Ionis Pharmaceuticals Lowers Tryngolza Price to Enhance Competitive Positioning

4d agoNewsfilter

When Insider Selling Can Be Positive: 2 Stocks to Keep an Eye On

Mar 23 2026Marketbeat

Ionis Pharmaceuticals Receives FDA Priority Review for Zilganersen

Mar 23 2026seekingalpha

Ionis Pharmaceuticals Receives FDA Priority Review for Zilganersen

Mar 23 2026Newsfilter

U.S.-Iran Conflict Triggers Volatility in Healthcare Stocks

Mar 16 2026seekingalpha

UniQure's Gene Therapy Faces FDA Challenges

Mar 05 2026CNBC

IONS Events

No data

No data

IONS Monitor News

Ionis Pharmaceuticals Receives FDA Priority Review for Zilganersen

Mar 25 2026

Ionis Pharmaceuticals Presents DAWNZERA Data at AAAAI 2026

Mar 05 2026

Ionis Pharmaceuticals Receives FDA Priority Review for Olezarsen

Mar 03 2026

Ionis Pharmaceuticals Reports Q4 Earnings Miss Amid Investor Conference Participation

Feb 25 2026

Ionis Pharmaceuticals reaches 52-week high amid positive trial results

Jan 07 2026

IONS.O Hits 52-Week High Amid Positive Momentum

Nov 24 2025

IONS Earnings Analysis

Ionis Pharma Earnings: Financial Growth & Strategy- Intellectia AI™
1 years ago

People Also Watch